Subscriber Content Read Preview
Ranbaxy Laboratories has discontinued a drug discovery and clinical development collaboration with Merck aimed at developing new anti-bacterial and anti-fungal drugs, a spokesman for the Indian drug maker said.
FDA Deputy Commissioner Joshua Sharfstein, who has advocated stronger safety standards, is leaving the agency to take the top public-health job for the state of Maryland.
Subscriber Content Read Preview
With biopharmaceutical company MannKind awaiting word from the FDA on its key product candidate, an inhalable form of insulin, CEO Alfred Mann has spent more than $22 million in recent months to add to his already considerable holdings of company shares.
Subscriber Content Read Preview
Euromedic has sold its kidney dialysis division to Fresenius Medical Care for €485 million ($648.5 million), the companies said.
Subscriber Content Read Preview
Pfizer has expanded its collaboration with drug maker Santaris Pharma, agreeing to a development and commercialization pact that could see it paying as much as $600 million.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
View an interactive map that shows you how stocks in the Pharmaceuticals & Biotech sector are doing today, at a glance.
Get in-depth research on Pharmaceuticals & Biotech companies, including complete news and financials, earnings estimates and more.
Ask a question about anything you choose, and let readers from the Journal Community answer it.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)